We noted significant increases in serum corticosterone in middle-aged MS male rats, accompanied by reduced serum levels of trophic factors, brain-derived neurotrophic factor (BDNF), and insulin-like growth factor-1 (IGF1). Here, IGF1 is linked to myeloid sarcoma.